DIANNE AVEY: Open Payments
NPI 1740215755 · GIG HARBOR, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 48 payments from 19 companies in 2025. Trend: 2023 $37 · 2024 $99 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $304 |
| Corcept Therapeutics | 3 | $99 |
| PFIZER INC. | 3 | $70 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 6 | $39 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Novo Nordisk Inc | 1 | $27 |
| Insulet Corporation | 1 | $26 |
| Amgen Inc. | 1 | $25 |
Products named: UBRELVY, QULIPTA, Korlym, NURTEC ODT, JOURNAVX, VOQUEZNA, CAPVAXIVE, Wegovy.
Industry payments across WA — which companies pay providers there.
